Showing results (871-880 of 2,823) with videos related to
Sort By:
Pageof 283
Cytotherapy|December 31, 2017
Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical centerFenlu Zhu, Nirav Shah, Huiqing Xu, et al.Cytotherapy|January 1, 2018
Mineralization by mesenchymal stromal cells is variously modulated depending on commercial platelet lysate preparationsFederica Boraldi, Jorge S Burns, Angelica Bartolomeo, et al.Cytotherapy|November 27, 2018
Cell sheet technology: a promising strategy in regenerative medicineMinxiong Li, Jun Ma, Yanbin Gao, et al.Cytotherapy|December 4, 2018
Morphological profiling using machine learning reveals emergent subpopulations of interferon-γ-stimulated mesenchymal stromal cells that predict immunosuppressionRoss A Marklein, Matthew W Klinker, Katherine A Drake, et al.Cytotherapy|December 26, 2018
A phase II randomized clinical trial for the treatment of recalcitrant chronic leg ulcers using centrifuged adipose tissue containing progenitor cellsIlaria Zollino, Diana Campioni, Maria Grazia Sibilla, et al.Cytotherapy|January 1, 2019
Mesenchymal stromal cells from infants with simple polydactyly modulate immune responses more efficiently than adult mesenchymal stromal cellsVamsee D Myneni, Ian McClain-Caldwell, Daniel Martin, et al.Cytotherapy|December 23, 2017
Exosomes from mesenchymal stromal cells enhance imatinib-induced apoptosis in human leukemia cells via activation of caspase signaling pathwayYing Liu, Baoquan Song, Yimeng Wei, et al.Cytotherapy|December 16, 2019
Autologous cryopreserved leukapheresis cellular material for chimeric antigen receptor-T cell manufactureSeshu Tyagarajan, David Schmitt, Christopher Acker, et al.Cytotherapy|December 16, 2019
Streamlined production of genetically modified T cells with activation, transduction and expansion in closed-system G-Rex bioreactorsChristine Gagliardi, Mariam Khalil, Aaron E FosterCytotherapy|December 28, 2019
Low baseline platelet count predicts poor response to plerixafor in patients with multiple myeloma undergoing autologous stem cell mobilizationMohammed Bakeer, Abba C Zubair, Vivek RoyPageof 283